✦ LIBER ✦

Frequency of Edema in Patients With Pulmonary Arterial Hypertension Receiving Ambrisentan

✍ Scribed by Shelley Shapiro; David M. Pollock; Hunter Gillies; Noreen Henig; Martine Allard; Christiana Blair; Crystal Anglen; Donald E. Kohan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Hepatic Safety of Ambrisentan

✍ Ori Ben-Yehuda; David Pizzuti; Andrea Brown; Marcus Littman; Hunter Gillies; Nor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Long-Term Outcomes With Ambrisentan Mono

✍ Shannon E. Blalock; Susan Matulevicius; Laura C. Mitchell; Sharon Reimold; John 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Long-Term Pulmonary Hemodynamic Effects

✍ James R. Klinger; Ronald J. Oudiz; Rebecca Spence; Darrin Despain; Christopher D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Interaction of ambrisentan and phenproco

✍ Sommer, Natascha; Grimminger, Jan; Ghofrani, Hossein A.; Tiede, Henning 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Frequency of Supraventricular Arrhythmia

✍ Wen, Li; Sun, Ming-Li; An, Pei; Jiang, Xin; Sun, Kai; Zheng, Lu; Liu, Qian-Qian; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 331 KB

152 Post-Marketing Hepatic Safety Profil

✍ D.B. Badesch; T. Peschel; D. Pizzuti; H. Gillies; M. Allard; C. Blair; M. Littma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 87 KB